Ledger.Open graph →
SEC Form D · filed February 1, 2021

NeuroBo Pharmaceuticals, Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Jeong Gyun J. Oh · Boston, MADirectorYeon J. Kim · Boston, MADirectorRichard J. Kang · Boston, MAExec · DirectorJason J. Groves · Boston, MADirectorNicola J. Shannon · Boston, MAExecMichael J. Salsbury · Boston, MADirectorDouglas J. Swirsky · Boston, MADirectorAkash J. Bakshi · Boston, MAExec · DirectorDerek Dunlop · Dallas, TXDirectorMichael Gaubert · Dallas, TXDirectorJoshua J. Widoff · Denver, COExec · DirectorJeffrey Baird · Oakland, CAExecPatrick Sakala · George Town, Cayman IslandsExec · DirectorDeborah D. Flickinger · Los Angeles, CADirectorMichael J. Salsbury · Boston, MADirectorItay Goren · Wilmington, DEDirectorJohn Monteiro · Dallas, TXDirectorCharlie Yue · Dallas, TXDirectorBrad Perry · Dallas, TXDirectorWilliam Hancock · DALLAS, TXDirectorPriya Kashyap · Dallas, TXExecVictor Whitmore · Tulsa, OKExec · DirectorThomas Cahill · Miami, FLExec · DirectorMelissa Bethell · London, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗